ECOG-EA8212-BRIDGE
Phase III
OPEN TO ACCRUAL
A Randomized Phase III Trial of Intravesical BCG veRsus Intravesical Docetaxel and GEmcitabine Treatment in BCG Naïve High Grade Non-Muscle Invasive Bladder Cancer (BRIDGE)
ENGENE-EG-70-101-LEGEND
Phase I/II
OPEN TO ACCRUAL
A Phase 1/2 Study of EG-70 As an Intravesical Administration to Patients with BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) and High-Risk NMIBC Patients Who Are BCG Naïve or Received Incomplete BCG Treatment